99mTc-labelled macroaggregated albumin (MAA) scintigraphy for planning treatment with 90Y microspheres
- 4 August 2010
- journal article
- research article
- Published by Springer Science and Business Media LLC in European Journal of Nuclear Medicine and Molecular Imaging
- Vol. 37 (12), 2328-2333
- https://doi.org/10.1007/s00259-010-1566-2
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Radioembolization of Liver Tumors With Yttrium-90 MicrospheresSeminars in Nuclear Medicine, 2010
- First experience of hepatic radioembolization using microspheres labelled with yttrium-90 (TheraSphere): practical aspects concerning its implementationEuropean Journal of Nuclear Medicine and Molecular Imaging, 2009
- SPECT/CT with 99mTc-MAA in Radioembolization with 90Y Microspheres in Patients with Hepatocellular CancerJournal of Nuclear Medicine, 2009
- Multimodality imaging can predict the metabolic response of unresectable colorectal liver metastases to radioembolization therapy with Yttrium-90 labeled resin microspheresPhysics in Medicine & Biology, 2008
- Recommendations for Radioembolization of Hepatic Malignancies Using Yttrium-90 Microsphere Brachytherapy: A Consensus Panel Report from the Radioembolization Brachytherapy Oncology ConsortiumInternational Journal of Radiation Oncology*Biology*Physics, 2007
- Radioembolization using 90Y-resin microspheres for patients with advanced hepatocellular carcinomaInternational Journal of Radiation Oncology*Biology*Physics, 2006
- Global Cancer Statistics, 2002CA: A Cancer Journal for Clinicians, 2005
- Clinical evaluation of the partition model for estimating radiation doses from yttrium-90 microspheres in the treatment of hepatic cancerEuropean Journal of Nuclear Medicine and Molecular Imaging, 1997
- Radionuclide transformations. Energy and intensity of emissions. Report of a Task Group of Committee 2 of the International Commission on Radiological Protection on data used in ICRP Publication 30.1983